Beyond cholesterol: The atherogenic consequences of combined dyslipidemia

Journal of Pediatrics

Volumn 161, Issue 6, 2012, Pages 977-979

  Kavey, Rae Ellen W ^a   Mietus Snyder, Michele ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; CVD; HDL; HDL C; High density lipoprotein; High density lipoprotein cholesterol; IDL; Intermediate density lipoprotein; LDL; LDL C; Low density lipoprotein; Low density lipoprotein cholesterol; TC; TG; Total cholesterol; Triglycerides; Very low density lipoprotein; VLDL

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; DYSLIPIDEMIA; EDITORIAL; LIPID METABOLISM; PARTICLE SIZE; PRIORITY JOURNAL;

CHOLESTEROL, HDL; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; OVERWEIGHT; PARTICLE SIZE; TRIGLYCERIDES;

EID: 84869501165     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2012.07.034     Document Type: Editorial

References (19)

1. D.M. Lloyd-Jones, Y. Hong, D. Mozafferian, L.J. Appel, L. Van Hoen, and G. Greenlund Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's Strategic Impact Goal through 2020 and beyond Circulation 121 2010 586 613
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
3. S.M. Grundy Use of emerging lipoprotein risk factors in assessment of cardiovascular risk JAMA 307 2012 2540 2541
4. S.F. Burns, S.J. Lee, and S.A. Arslanian Surrogate lipid markers for small dense LDL particles in overweight youth J Pediatr 161 2012 991 996
5. S.J. Robins, A. Lyass, J.P. Zachariah, J.M. Massaro, and R.S. Vasan Insulin resistance and the relationship of a dyslipidemia to coronary heart disease: the Framingham Heart Study Arterioscler Thromb Vasc Biol 31 2011 1208 1214
6. C.J. Packard, T. Demant, J.P. Stewart, D. Bedford, M.J. Caslake, and G. Schwertfeger Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions J Lipid Res 41 2000 305 318
7. W.C. Cromwell, J.D. Otvos, and M.J. Keyes LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study: implications for LDL management J Clin Lipidol 1 2007 583 592
8. J.D. Otvos, S. Mora, I. Shalaurova, P. Greenland, R.H. Mackey, and D.C. Goff Jr. Clinical implications of discordance between low-density lipoprotein cholesterol and particle number J Clin Lipidol 5 2011 105 113
9. M. Tamminen, G. Mottino, J.H. Qiao, J.L. Breslow, and J.S. Frank Ultrastructure of early lipid accumulation in ApoE-deficient mice Arterioscler Thromb Vasc Biol 19 1999 847 853
10. J. Shalhoub, M.A. Falck-Hansen, A.H. Davies, and C. Monaco Innate immunity and monocyte-macrophage activation in atherosclerosis J Inflamm (Lond) 8 2011 1 17
11. I. Tabas, K.J. Williams, and J. Boren Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications Circulation 116 2007 1832 1844
12. R.-E. Kavey, D.G. Simons-Morton, and J.M. DeJesus Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: summary report Pediatrics 128 Suppl 6 2011 S1 44
13. M.G. Frontini, S.R. Srinivasan, J. Xu, R. Tang, M.G. Bond, and G.S. Berenson Usefulness of childhood non-high-density lipoprotein cholesterol levels versus other lipoprotein measures in predicting adult subclinical atherosclerosis: the Bogalusa Heart Study Pediatrics 121 2008 924 929
14. J. Liu, C.T. Sempos, R.P. Donahue, J. Dorn, M. Trevisan, and S.M. Grundy Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease Am J Cardiol 98 2006 1363 1368
15. A.E. Sumner Ethnic differences in triglyceride levels and high-density lipoprotein lead to underdiagnosis of the metabolic syndrome in black children and adults J Pediatr 155 2009 S7 e7 S7.11
16. H.C. McGill, C.A. McMahan, and S.S. Gidding Are pediatricians responsible for prevention of adult cardiovascular disease? Nat Clin Pract Cardiovasc Med 6 2009 10 11
17. J.D. Berry, A. Dyer, X. Cai, D.B. Garside, H. Ning, and T.A. Greenland Lifetime risks of cardiovascular disease N Engl J Med 366 2012 321 329
18. T. Koivistoinen, N. Hutri-Kahonen, M. Juonala, T. Koobi, T. Lehtimaki, and J.S. Viikari Apolipoprotein B is related to arterial pulse wave velocity in young adults: the Cardiovascular Risk in Young Finns Study Atherosclerosis 214 2011 220 224
19. J. Rodenburg, M.N. Vissers, A. Wiegman, A.S. van Trotsenburg, A. van der Graaf, and E. de Groot Statin treatment in children with familial hypercholesterolemia: the younger, the better Circulation 116 2007 664 668